Tailored postoperative treatment of prostate cancer: final results of a phase I/II trial

BACKGROUD: The European Organization for Research and Treatment of Cancer (EORTC) trial 22,911 reported 74% 5-year biochemical disease-free survival (bDFS) in patients with prostate carcinoma treated with radical prostatectomy (RP) followed by postoperative radiotherapy (RT). This study aimed to imp...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Prostate Cancer Prostatic Dis
Main Authors: Mantini, Giovanna, Siepe, Giambattista, Alitto, Anna Rita, Buwenge, Milly, Nguyen, Nam P., Farioli, Andrea, Schiavina, Riccardo, Catucci, Francesco, Deodato, Francesco, Fionda, Bruno, Frascino, Vincenzo, Macchia, Gabriella, Ntreta, Maria, Padula, Gilbert D. A., Arcelli, Alessandra, Cammelli, Silvia, Rambaldi, Giuseppe Zanirato, Cilla, Savino, Valentini, Vincenzo, Morganti, Alessio G.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6283858/
https://ncbi.nlm.nih.gov/pubmed/30038390
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41391-018-0064-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados